ANTI-HYPERPROLIFERATIVE THERAPIES TARGETING HDGF

摘要

The present invention provides methods of cancer therapy or diagnosis involving targeting hepatoma-derived growth factor (HDGF). In certain embodiments, an antibody and/or siRNA may be used to inhibit HDGF, optionally coupled to or combined with other cancer therapies.